Larvol Delta - Efficacy-and-Safety-of-IMVT1402-in-Adult-Participants-With-Primary-Sjogren39s-Disease-With-Moderate-to-Severe-Systemic-Disease-Activity

imeroprubart (IMVT-1402) - Immunovant, HanAll Biopharma

http://clinicaltrials.gov/ct2/show/NCT06979531

Sep 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next